Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
SHIRE US, INC. v. ALLERGAN, INC. et al
Case Number:
2:17-cv-07716
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
May 29, 2019
Allergan Looks To Have Shire's Eye Drug Suit Tossed Again
Allergan has once again asked a New Jersey federal judge to dismiss a suit by Shire accusing it of having a "stranglehold" on the Medicare market for dry-eye drugs, saying the complaint is just a rehash of an older one that was dismissed.
-
March 26, 2019
Allergan Gets Shire's Dry-Eye Drug Antitrust Suit Dropped
A New Jersey federal judge has dismissed Shire's suit accusing Allergan of having a "stranglehold" on the Medicare market for dry-eye drugs after finding that the pharmaceutical company failed to prove that the conduct it was protesting was anti-competitive.
-
August 31, 2018
Pharma Cases To Watch In 2018's Home Stretch
Drugmakers in the closing months of 2018 may see pivotal rulings on novel efforts to hamstring rival medicines, escalating drama in multidistrict litigation over the opioid epidemic, and opening salvos in False Claims Act and drug-pricing fights at the U.S. Supreme Court. Here, Law360 summarizes key cases to watch.
-
August 29, 2018
Allergan, Shire Spar Over Pfizer-J&J Antitrust Ruling
Allergan and Shire are trading blows over a recent ruling that kept alive Pfizer's antitrust suit against Johnson & Johnson over alleged coercion of health insurers, debating whether it lends credence to similar coercion allegations against Allergan.
-
January 24, 2018
Shire Rips Allergan's 'Stranglehold' On Dry-Eye Drug Market
Shire PLC on Tuesday tore into Allergan Inc.'s effort to escape antitrust litigation over its "stranglehold" on Medicare business for dry-eye drugs, accusing Allergan of disingenuously claiming Medicare Part D isn't a distinct market.
-
December 06, 2017
Allergan Says Shire Suit Upends 'Very Fabric' Of Antitrust Law
Shire's recent claims that Allergan Inc. improperly discounted various drugs in an attempt to keep Medicare Part D beneficiaries from using Shire's competing treatment for dry eyes "runs counter to the very fabric" of antitrust law, Allergan told a New Jersey federal court on Tuesday.
-
October 02, 2017
Shire Hits Allergan With Antitrust Suit Over Dry Eye Drugs
Allergan Inc. has engaged in anti-competitive conduct in an effort to block Medicare Part D beneficiaries from purchasing Shire U.S. Inc.'s competing treatment for dry eye disease, a suit filed Monday in New Jersey federal court claims.